A Skin Substitute Reepithelialization Calculator for Natural, Synthetic,  and Composite Skin Cell Scaffolds by Williams, Miguel
A Skin Substitute Reepithelialization
Calculator for Natural, Synthetic,
and Composite Skin Cell Scaffolds
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Williams, Miguel. 2017. A Skin Substitute Reepithelialization
Calculator for Natural, Synthetic, and Composite Skin Cell Scaffolds.
Master's thesis, Harvard Extension School.
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:33813409
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
  
 
 
A Skin Substitute Reepithelialization Calculator For Natural, Synthetic,  
And Composite Skin Cell Scaffolds 
 
 
 
 
 
 
Miguel Williams 
 
 
 
 
 
A Thesis in the Field of Biotechnology for the Degree of Master 
of Liberal Arts in Extension Studies 
 
 
Harvard University  
March 2017 
 
  
  
 
 
  
  
 
Abstract 
 
 
Tissue engineering is a rapidly advancing field. Researchers around the globe 
have been working on novel ways to replicate the natural properties of tissues and organs. 
While new technologies enable increasingly complex therapeutics few of them have been 
found to be acceptable for clinical use. The skin is an excellent test bed for the techniques 
necessary for organ replacement. Skin is naturally regenerative, easily accessible and not 
as metabolically active as many other organs. This study analyzes published work to 
compare the epithelial wound repair rates of natural, synthetic, and hybrid tissue 
engineered skin substitutes to develop a wound repair calculator. Over 1,000 data points 
were utilized from 232 papers, linear regression produced a wound repair rate equal to 
the amount of wound repair per hour for each therapeutic class. Repair rates varied 
widely both within and across different therapeutics. Precision tests of the calculator’s 
accuracy using 30 papers produced little concordance. The data reported in the tissue 
engineering papers examined here vary too greatly for accurate predictions of 
reepithelialization suggesting that the driving force in wound repair is not being 
effectively accounted for within the published works. 
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Chapter I 
Introduction 
 
 
During the past hundred years the principal challenges facing modern medicine 
have shifted. The primary cause of mortality is no longer infectious diseases, instead 
degenerative and chronic conditions such as cancer and diabetes have become the greater 
unmet need (Armstrong, Conn, & Pinner, 1999). These maladies have specific molecular 
underpinnings which expand to impair organ and system function. Many current medical 
therapies, which broadly modulate the body’s physiology, are ill suited to the precision 
applications necessary to truly cure these chronic conditions. For example, the current 
standard of care for a skin abscess in a diabetic patient is surgical drainage and 
debridement. However this procedure only mitigates further damage rather than actually 
improving the movement of nutrients in the extremity (Cahn & Y, 2014).  An alternative 
strategy for treating such ailments is to circumvent the innate repair process by replacing 
the tissue with a synthetic analog. The need for engineered tissues extends beyond the 
realm of therapeutics into whole organ replacement. Demand for organ transplants 
already far outpaces the pool of donors by tens of thousands,  and the projected need  is 
accelerating (“Introduction,” 2015). 
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The Potential of Tissue Engineering 
Tissue engineering is a burgeoning field dedicated to using synthetic processes to 
supplement natural tissues.  With advances in chemical engineering, cell culture and 
molecular biology it is now possible to replicate natural structures at nanometer 
resolutions. These therapeutics are called biomaterials, they are defined as products 
which can integrate with host tissue with minimal rejection. Such therapies are often 
comprised of three portions: replacement cells, cell scaffolds, and signaling molecules to 
promote proper function.  Of these three components the scaffold is particularly 
important as it serves multiple roles in tissue regulation; scaffolds simultaneously 
influence the cellular adhesion, homeostasis and tissue ultrastructure. Tissue engineering 
products have already been applied clinically to replace a variety of different tissues 
(Williams & Bhatia, 2014). While the advancements in preclinical applications have been 
impressive there have been few products which actually graduate to clinical applications. 
There are many factors which contribute to this clinical barrier including an imperfect 
model of organ synthesis and repair, challenges in vascularization and the extensive 
testing necessary for validating novel therapeutics. 
Ironically, the greatest impediment to clinical tissue engineering may be the 
success of laboratory tissue engineering. Researchers have combined different 
technologies to produce a plethora of potential therapeutics. Cell scaffolds, for example, 
can vary by substrate, polymer length, purity, pore size, ultrastructure, and fabrication 
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method. A single variable can elicit different cellular responses from an otherwise 
identical applications (O’Brien, Harley, Yannas, & Gibson, 2005).  
Additional variables such as effectors, the type of cell being applied, cellular 
passage number, purity of the applied cells, and therapeutic application further conflates 
the issue. While the complexity of tissue engineering will likely necessitate a toolbox of 
techniques rather than a single solution, the plethora of variables seen in current studies 
dissuade standardization. This in turn prevents the formation of a foundation upon which 
further work can be based. Recent publications from the journal Tissue Engineering Part 
A utilized disparate cellular scaffolds to create full thickness epidermal tissues including 
polyvinyl alcohol-collagen-glycosaminoglycan (PVA)-(GAG) (Roessner et al. 2011),  
fibrin (Helmedag et al., 2014) and hyaluronic acid (Wu et al., 2014). Each of these 
designs had different beneficial properties but the absence of standard metrics and data 
analysis creates three different therapies for three different injuries rather than three 
methods of approaching one therapy. 
The need for better standards in tissue engineering has been voiced by 
organizations such as The American Society of Testing and Materials (ASTM) and the 
Alliance for Regenerative Medicine, yet best practice guidelines are still lacking (Simon 
et al., 2015). The standards that do exist are only used sparingly. The National Institute of 
Science and Technology reference scaffolds, for example, are likely cost prohibitive for 
most research at $250 per sample. Similarly the ASTM tissue engineering guides are only 
suggestive outlines, rather than methodical practices. It is estimated that they are only 
used by around 0.3% of tissue engineering studies (Simon et al., 2015). Implementing 
universal standards is almost as complex a task as designing a therapeutic device, such 
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standards would need to bridge gaps between a wide variety of technologies while 
covering an equally wide variety of metrics. An ideal standard would produce precise 
measurements of cell seeding, adhesion, mortality, biocompatibility, distribution and 
proliferation across a wide variety of tissue engineering applications. Clearly, a set of 
standards rather than a single all purpose will be required to be applied to different 
therapeutics similarly to how different therapies will be required for different medical 
problems.  
While standards would improve future work they cannot be applied retroactively 
to the thousands of studies already published. There may be unseen unifying trends 
already present in the hundreds of published results. Large scale analysis of this body of 
work could be used to find patterns in the absence unifying metrics. For my thesis project 
I would like to develop a cellular scaffold calculator to predict cell survival within skin 
scaffolds based on pore size, biomaterial concentration and cellular seeding density.  
Studies will be restricted to those containing hydrogel in situ applications of collagen, 
polyester and collagen-polyester composites scaffolds in rodents as skin tissue engineered 
therapeutics. These three different scaffold types are often used and serve as 
representatives of natural, synthetic and composite cell scaffolds, respectively.  
By comparing between control and experimental groups the average effect of 
each component within the scaffold can be assessed. The large data set decouples the 
effect of the biomaterial from the effectors resulting in a quantitative measurement and 
allowing for relative comparisons across different scaffolds. This standardization will aid 
in the precision design of future cellular scaffolds, by relating properties of the cell 
scaffolds with predictable outcomes.     
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 Tissue engineering therapies need to be designed to specifically mimic the tissue 
to which they are being applied. Experimental variables conflate the effects of the 
therapeutics design with specific application. The cell survival calculator will decouple 
these two factors by defining the expected results for specific designs a priori. For 
example, vascular endothelial growth factor (VEGF), is often used to improve the 
angiogenesis in tissue engineering therapeutics, but it also activates cell survival 
pathways (Byrne, Bouchier-Hayes, & Harmey, 2005). A single study that demonstrated 
improved cell survival when cells were applied with VEGF would be unable to identify if 
the increased survival would be due to the survival signaling or from changes in the 
surrounding tissue. The cell survival calculator would provide an effective baseline; a 
researcher could compare their study to the expected survival rates as well as compare 
their study to other studies run with VEGF.  
Hitherto most meta-analysis of cell scaffolds has focused on physical properties 
and therapeutic efficacy while ignoring cell survival (Deng et al., 2015). Cell survival and 
engraftment are probably the most important metrics that can be attributed to 
therapeutics, as they represent how closely the microenvironment promotes homeostasis. 
The cell survival calculator could be used to start reframing the methodology used in 
tissue engineering. Ideally, it would help researches shift their focus from experimental 
testing novel products to hypothesis testing of predicted outcomes. 
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Natural Properties of the Extracellular Matrix 
 
 The extracellular matrix (ECM) is the network compounds that bind, organize and 
regulate cellular structure within tissues. Though chiefly composed of proteins, the 
makeup of the ECM is tissue and location dependant, cells extrude ECM proteins as they 
expand mitotically in response to the extracellular environment. It should be noted that 
conventionally an ECM refers to a naturally occurring organic connective tissue matrix, 
whereas a cell scaffold is a man made tissue engineering construct. The crosstalk between 
the ECM and the cells which it envelops influence the homeostasis and metabolic 
processes for the duration of the tissue’s life (B. P. Chan and Leong 2008). Tissue 
function can be further regulated intrinsically through the composition, rigidity, 
topography and ultrastructure or extrinsically through signaling models like growth 
factors, cytokines and chemokines (Curtis, Dalby, & Gadegaard, 2006). The intrinsic and 
extrinsic signals influence differentiation, proliferation, localization and homeostasis (see 
figure 1).  
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Figure 1. Relationships between the ECM, cells and signaling molecules. This visualizes 
the crosstalk between the three principle components of most tissue engineering 
therapeutics. 
 
 
The ECM is mediated both through cellular extrusions and through interstitial proteases 
and inhibitors, this relationship creates a system of dynamic reciprocity (Birkedal-
Hansen, 1995). These mechanisms help direct tissue response as a whole.  
 The ECM is mostly composed of collagen, in fact collagen is the most abundant 
protein in the human body. Collagen polymers naturally intertwine to form long fibrils. 
The tendons and cartilage have a high content of collagen fibrils; the elasticity and tensile 
strength that they require are representative of the properties which collagen can produce 
(Hynes, 2012). Additional polymers such as glycoproteins and proteoglycans are present 
throughout the collagen foundation of the ECM producing properties specific to each 
tissue (Buck & Horwitz, 1987).
 Glycoproteins connect the ECM polymers or cells. Fibronectin binds, cells, 
collagen, heparin sulfate and fibrin, its motifs were used to develop the RGD adhesion 
peptides often used in cell scaffolding and cell culture (Järveläinen, Sainio, Koulu, 
Wight, & Penttinen, 2009). Elastin is a glycoprotein that allows materials to stretch, 
making them simultaneously plaint and resilient, it is found in tissues such as the lungs 
and skin  (Bosman & Stamenkovic, 2003). Proteoglycans are polymerized disaccharides 
with covalently bound core protein, in addition to structural diversity properties are 
modified through bound co-receptors, morphogens, and cell adhesion proteins.  
Signaling factors, such as VEGF or fibroblast growth factor (FGF) may be bound 
to specific ECM polymers (Zhu, Oganesian, Keene, & Sandell, 1999). These signaling 
factors may interact directly with cells or complex with other domains such as integrins 
to induce further signaling. The spatial relationships of receptor complexes influence the 
downstream signal cascades, introducing another layer of regulation (Wijelath et al., 
2006). Free floating signaling molecules such as transforming growth factor-beta (TGF-
B)  may be bound by the ECM, they are released upon remodeling or cleavage by matrix 
metalloproteinases (Hynes, 2012). The ECM can also enable activation of TGF-B by 
binding inhibitors or presenting active sites to cellular receptors (Wipff & Hinz, 2008).  
Adhesion molecules such as integrins and cadherins are built into the matrix, 
facilitating the localized attachment of specific cells (Uriel et al., 2009). Cellular focal 
adhesions connect receptors in the ECM to the cellular membrane and cytoskeleton, 
actively binding and signaling the cell simultaneously. The rate of ECM turnover is also 
governed by the concentration of cleavage sites within the polymers. Cellular secreted 
proteases break down nearby ECM components creating space for newly synthesized 
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networks. Tissue engineers are just beginning to imbue cell scaffolds with the complex 
spatial and temporal signals seen in natural ECMs (Ghosh and Ingber 2007). 
 The most important property of the ECM, and the most challenging to replicate 
synthetically, is the constant state of remodeling. Cells anabolically extrude matrix 
proteins and catabolically extrude proteases, building and deconstructing the local ECM 
as necessary (Larsen, Artym, Green, & Yamada, 2006). Building up the ECM at a rate 
greater than it can be broken down produces fibrotic tissue which in turn produces 
inflammation  (Raghow, 1994). Conversely limited ECM extrusion weakens tissue 
cohesion and induces cell death through anoikis (Gilmore, 2005) .  An artificial cell 
scaffold must be either bioabsorbable with a degradation rate equal to ECM synthesis or 
be maximally biocompatible, producing a minimized inflammatory response. The 
remodeling rate of the ECM varies by tissue and metabolic state. It is exceedingly 
challenging to produce a device which can meet the mechanical and temporal 
requirements of the natural ECM.  
 The cell scaffold survival calculator will inform future studies by providing 
benchmarks for both prescriptive design and post hoc analysis.  Prescriptively, the cell 
scaffold survival calculator can be used to ensure that the therapeutics’ design and the 
clinical goals are aligned. If cells are not projected to survive the lifespan of the 
therapeutic, redesigns may be necessary for maximal efficacy. Conversely when a 
therapeutics cell survival is different than what is predicted it may indicate that the 
scaffold contains elements which significantly influence survival. These discrepancies 
will drive tissue engineering research by highlighting design elements to avoid or 
incorporate for future work.  
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Discrepancies Between Cell Scaffolds and the Natural ECM 
 
Tissue engineering products can be composed of natural biomaterials, which are 
organic compounds produced in nature, or they can be composed of synthetic 
biomaterials which are man-made. Cell scaffolds are designed to be biometric but there is 
a wide gulf between what can be fabricated and the properties cells experience within 
tissues. Natural biomaterials often exhibit emergent properties, producing characteristics 
greater than the sum of their parts. Mollusk shells for example, are composed of 
aragonite, but the complex patterning makes the shell 3,000-10,000 times tougher than 
inorganic aragonite (Dean, Swanson, and Summers 2009). 
 
 
Table 1 
Physical properties of differently sourced elastin. 
The synthetic elastin described here is a recombinant human tropoelastin, 
cross-linked with bis(sulfosuccinimidyl) substrate. 
Protein Origin 
Elastic 
modulus 
Strength 
(stress at 
break) 
Extensibility 
(strain at 
break) 
Elastin 
Bovine nuchal 
ligament 1.1 MPa 2 MPa 150% 
Porcine aorta 0.81 MPa 
1.02 
MPa 103% 
Synthetic 
0.22–0.28 
MPa 
~ 0.4 
MPa 200–370% 
Note: Table originally reported in (Muiznieks and Keeley 2013). 
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Current fabrication methods are unable to reproduce the complex patterns seen in nature, 
so even cellular scaffolds made from identical macromolecules have different physical 
properties than the ECM observed in tissue. This discrepancy is present at the 
microscopic level and then expands at the level of tissue wide ultrastructure (see Table 
1). 
One strategy use to minimize this discrepancy is to use blends of natural and 
synthetic biomaterials, called hybrid or composite scaffolds. These scaffolds afford the 
tunability of synthetic scaffolds and the biocompatibility of natural scaffolds.  
As the properties that go into making the ECM influence the properties of the 
tissue, the fabrication parameters affect the properties of the cell scaffold. Collagen cell 
scaffolds are affected by the material source, the pH at polymerization, temperature, ionic 
strength and polymer concentration, macromolecule purity and the presence of any 
adulterants (Dado & Levenberg, 2009). These characteristics impact the mechanical 
properties, structure and porosity. While these factors have been shown to be important 
they are not always reported in papers, this is partially due to the technical challenges 
involved in proper evaluation. Structural measurements are particularly challenging as 
there are currently no automated image analysis methods.  
In addition to the development of novel therapeutics the cell scaffold calculator 
could be used to discover unknown biological mechanisms. Comparing interactions 
across multiple applications could identify effectors which produce a significant change 
which is only apparent in aggregation rather than single studies. These unknown factors 
may represent undiscovered metabolic mechanisms and could be fruitful avenues of 
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research for future studies. Alternatively these effectors could be used to interrogate 
cellular repair and growth in model systems.  
 
Tissue Engineering 
 
 Cell scaffolds are often classified by three categories; material, fabrication, and 
assembly. These three properties have the greatest effect on the overall relationship 
between the scaffold and the host tissue, but they are by no means an exhaustive 
accounting of all the factors which produce a physiological response.  The materials are 
either naturally compounds, synthetic compounds or a composite of the two. Natural 
materials integrate well with the body’s homeostasis but are often harder to manipulate. 
Tissue engineers have greater control of synthetic products, but synthetics are more likely 
to produce a response from the body through processes like inflammation (Jiang, Liang, 
& Noble, 2010). Fabrication can be classified as either top down or bottom up. In top 
down fabrication complex structures are disassembled to isolate the necessary 
therapeutic, such as when tissues are decellularized to obtain an ECM which is then 
reseeded with cells to create tissues (Bechtel et al., 2003). Bottom up fabrication takes 
place when component macromolecules are assembled to produce a novel structure, a 
hydrogel which is made with cross-linking polymers once in place is an exemplary 
product. Engineered products are either assembled ex vivo or in situ. Ex vivo therapies 
are processed in the lab and then transplanted into the patient, in situ therapies are applied 
directly to the patient, assembly takes place at the therapeutic site (“Wiley,” n.d.). All of 
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these different factors must be considered together to understand the properties of the 
scaffold and tissue product. 
Advancements in tissue engineering have afforded researchers the ability to 
replicate some of the properties of natural tissues but no scaffold has successfully 
recapitulated all of the natural complexities seen in the ECM. In trying to satisfy all of 
these distinct needs tissue engineering therapies are becoming increasingly complex. 
Functionalization and fit for purpose design are often used to tailor the therapeutic to the 
needs of the individual disease (Haag, Jungebluth, and Macchiarini 2013). Unfortunately 
this complexity increases the amount of splintering within the literature. Tissue 
engineering therapies applied to identical diseases may have completely different 
properties. Differentiated human embryonic stem cells and polytetrafluoroethylene 
patches can both be applied to a myocardial infarction but they produce vastly different 
physiological responses (Lakshmanan, Krishnan, & Sethuraman, 2012) (Shiba et al., 
2012). To effectively draw comparisons across different kinds of scaffolds in this thesis it 
is important to impose a set of selection criteria. 
The positive selection is described in detail in Chapter II: Selection Criteria, but 
with the variety of cell scaffolds to chose from, the negative selection criteria is just as 
crucial. The scaffolds analyzed in this thesis were chosen to be representative of 
biomaterials often used in tissue engineering. Scaffolds with unique physical and 
biological properties were excluded from analysis. Polyhedral oligomeric silsesquioxane 
poly(carbonate-urea) urethane for example, is a highly biomimetic compound with 
promising tissue engineering applications (Williams & Bhatia, 2014).  But it is a 
synthetic, non degradable, inert compound which is not reflective of natural compounds 
14 
 
or most synthetic biomaterials. Biomaterials which were rarely used in animal models 
were also excluded as they would not provide enough data for comparison. Similarly, 
highly functionalized scaffolds or scaffolds with many component monomers were 
excluded as it would be difficult to discern the effect of each biomaterial in the presence 
of numerous other bioactive motifs. 
 
 
Tissue Engineering Challenges 
 
 
Despite advanced functionalizations cell scaffolds are intrinsically different than a 
natural ECM. In an organism the ECM is extruded during gestational development, the 
ultrastructure expands concurrently with cellular mitosis. After the tissue has grown to its 
maximal size the ECM will then undergo physiological changes with the surround tissue 
(Rozario & DeSimone, 2010). By contrast cellular scaffolds are assembled first and then 
exposed to cells. An effective scaffold must concurrently allow for three discrete goals. 
First cell scaffolds must bind exogenous or host cells, second it must allow, if not 
facilitate, engraftment into the host tissue. Third, the cell scaffold must create an 
environment conducive to the restoration of normal tissue function. As the ECM is 
produced during tissue development the first and second goals are not seen 
simultaneously in nature. Though the ECM will replicate such properties sequentially 
during wound repair remodeling steps they are initiated over time and at small scales 
(Midwood, Williams, & Schwarzbauer, 2004). Materials that are amenable to fabrication 
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are often ill suited for structural stability and vice versa. Thus the ideal cell scaffolds 
should exhibit properties beyond the scope of any single ECM. 
 
 
Scaffold Functionalization 
To induce the desired properties within the therapeutic tissue engineers must be 
mindful of how cell scaffolds influence the overall tissue. The cell scaffold survival 
calculator will improve the practice of scaffold functionalization by defining the expected 
survival of cells grown within biomaterial matrices. Future studies will be able to identify 
the efficacy of each individual functionalization, developing a toolbox with which to 
tailor the overall tissue response. 
Current products already contain specific signaling motifs to produce the intended 
effect. One of the first things to consider is how cells bind to the scaffold; this is 
determined by many factors such as porosity, the substrate and the presence of any 
adhesion sites. Porosity must be carefully regulated, if the space between cells is too large 
the tissue will not maintain cohesion, if there is too little space between cells they will not 
be able to migrate into the scaffolds core (Murphy, Haugh, & O’Brien, 2010). Integrated 
ligands or adhesion motifs can be built into scaffolds to recruit cells (Schussler et al., 
2009).  
The three dimensional structure of an ECM dictates its overall properties; 
similarly the structure of a scaffold dictates its efficacy and engraftment into the hosts 
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tissues. Vascularization limits the size of an engineered tissue. Oxygen will only diffuse 
across a distance of about 100 µm, in the absence of proper gas exchange a tissue will 
develop necrotic regions (Haraguchi et al., 2010). Successful therapeutics must allow for 
the growth of new vasculature and allow for integration with the host vasculature at a rate 
proportional to tissue growth. These two properties are called angiogenesis and 
anastomosis respectively. Growth factors such as VEGF can improve vascularization 
(Ghanaati et al., 2011; Kucera, Doss, Dunn, Clemson, & Zwischenberger, 2007). In spite 
of these functionalizations the maximal size of in vitro engineered tissues is a few 
millimeters thick (Kaully, Kaufman-Francis, Lesman, & Levenberg, 2009). This remains 
a significant limitation in the clinical utility of engineered tissues.  
Appropriate loading of the cell scaffold, through design informed by the cell 
scaffold calculator will enable better products within the constraints of oxygen diffusion. 
The addition of more cells than the therapeutic can reasonably support only accelerates 
necrosis. The cell scaffold calculator can be used to suggest a maximal loading, the point 
at which higher concentrations of cells most likely die without conferring therapeutic 
benefit. More broadly the methodology employed in the cell scaffold survival calculator 
can be adapted to any quantitative variables.  
Tissue engineered products must be either permanent, maintaining lifelong 
biocompatibility or temporary where they are replaced by the natural ECM. Permanent 
cell scaffolds are unencumbered by considerations of degradation rates but they produce 
a higher risk of acute inflammation (Anderson, Rodriguez, & Chang, 2008). 
Bioabsorbable  biomaterials, which can be metabolically broken down within the body, 
allow for natural repair and integrate well with host tissues after the initial 
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implementation (Tamai et al., 2000)  .  However most bioabsorbable scaffolds are broken 
down by stochastic hydrolysis, ECM turnover is mediated primarily by secreted 
proteases, which is a more regulated process. While it is impossible to precisely replicate 
the regulated remodeling of the ECM with the chaotic degradation of cell scaffold 
polymers, hybrid biomaterials can be used to control remodeling. Laboratory 
measurements are often used to provide a rough estimate of remodeling rates to prevent 
catabolic tissue prolapse (Ike, Shimizu, Okada, Ikada, & Hitomi, 1991). 
The cell scaffold survival calculator will inform the precision of predicting ECM 
remodeling. Understanding the expected population of living cells is the first variable 
necessary for building a mathematical framework for ECM extrusion rates. Eventually, 
remodeling will be derived algorithmically rather than empirically. The calculator could 
be used to produce guidelines for future biomaterials. Understanding the expected cell 
death over device engraftment can be used to define target survival rates for new cell 
scaffolds. Discrepancies between the expected and observed cell survival can be used to 
identify the best therapeutic strategy. 
For example, an observation that 70% of cells do not survive past day 14 within 
most scaffolds could be used as a benchmark. It may be that scaffolds which have 
completely biodegraded by this point produce better host response. Conversely it could 
be that scaffolds which are still in place allow for host cells to take over the repair 
process from the exogenously introduced cells. The cell scaffold calculator could be used 
to compare between the two methodologies, identifying the best therapeutic strategy.  
ECM remodeling varies by tissue. The cell scaffold calculator will define expected 
results allowing for informed design and comparisons. Remodeling rates could be 
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compared across tissue rather than across therapeutics. A better understanding of cell 
scaffold remodeling would inform the broader physiological changes occurring during 
tissue repair. A tissue’s regenerative capacity is determined by many factors such as 
inflammatory response, tissue injury and the abundance of host stem cells. Different 
organs have markedly varied abilities to repair, from the highly regenerative liver to the 
brain which has limited ability to repair. Despite the range in capabilities the overall 
repair process is often conserved across tissues and the ECM is a crucial mediator to the 
tissue’s regenerative potential (see Table 2 in the appendix, page 52).  Understanding the 
remodeling process will provide a more contiguous spectrum of classification for the 
tissue repair process. This could lead to improved therapeutic efficacy through 
application at the optimal phase of wound repair and a more detailed understanding of the 
requirements of regeneration. This could lead to new therapeutic targets using cell 
scaffolds as the primary biological effector.  
 
Hydrogels 
 
Hydrogels are malleable solids made up of matrices in an aqueous solution. They 
are amenable to skin tissue engineering as they can be shaped to fit the required portion 
of skin. This study focuses on papers published with hydrogel cell scaffolds for several 
reasons. First hydrogels are often utilized for dermal applications, providing both a range 
of previously published works and a built in application for future work. Second, utilizing 
hydrogels circumvents potential computational complexities. It would be challenging to 
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compare survival in scaffolds with radically different size, thicknesses and application 
areas. Cells within a hydrogel are embedded within the scaffold stochastically, as the 
cells already vary between applications, there will be no explicit differences in 
ultrastructure design. 
Therapeutic cell scaffolds must mimic the ECM, remaining pliant enough to allow 
for movement while strong enough to provide structural support to multiple dermal layers 
and avoid tears. This study will focus on cell scaffolds used in skin therapies using 
collagen, polycaprolactone and hybrid collagen polycaprolactone scaffolds.  
 
 
 
Skin Tissue Engineering 
 
The skin is the largest organ in the body and is made up of three dermal layers. It 
simultaneously provides structural support and serves as a barrier to opportunistic 
pathogens.  The skin is one of the most regenerative organs but all three layers can only 
be repaired over a small surface area (Lei, You, & Andreadis, 2013). The outermost layer 
is the epidermis, it is mainly made up of keratinocytes. The ECM forms a heparin sulfate 
basement membrane containing proteoglycans to connect the lower levels, the dermis and 
epidermis. The basement membrane signals keratinocytes to differentiate into dermal 
cells with growth factors and cytokines (Breitkreutz, Mirancea, & Nischt, 2009). The 
dermis has a collagen ECM as well as elastin fibrils embedded with proteoglycans to bind 
cells. Fibroblasts which secrete the ECM are the primary cell type found in the dermis 
though macrophages are also present to prevent infection (F. A. Auger, Lacroix, and 
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Germain 2009). The hypodermis connects the dermal layers to muscle or bones via an 
elastin network, and is chiefly made up of macrophages, blood vessels, fibroblasts and 
adipocytes.  Skin replacements are broken into full and partial therapeutics depending if 
they include all three layers or merely the epidermal layer. Tissue engineered dermal 
layers must integrate into the host structure, be non-immunogenic, provide a temporary 
barrier and allow for self repair throughout the patient’s life.  
Over 20 tissue engineered skin products are currently on the market (F. A. Auger, 
Lacroix, and Germain 2009). These products utilize a wide range of strategies including 
acellular and cellular applications, utilizing xenograft byproducts, keratinocytes, and 
neonatal foreskin  (Jones, Currie, & Martin, 2002; Kirsner et al., 2012; D. Q. A. Nguyen, 
Potokar, & Price, 2010; Purdue et al., 1997). Currently only the therapeutic Apligraf has 
received FDA approval to be used as a full thickness skin substitute. Apligraf utilizes 
fibroblasts, seeded within a type 1 collagen matrix with a layer of differentiated 
keratinocytes (S. Hu, Kirsner, Falanga, Phillips, & Eaglstein, 2006) . The tissue contains 
growth factors and cytokines and is a solid barrier against pathogens and physical 
perturbation. Interestingly DNA from Apligraf cells was not found past 4 weeks when 
applied to patients, yet the wound closure was improved when compared to controls. This 
may suggest that Apligraf’s benefits are not conferred by cells (S. Hu et al., 2006).  
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Collagen 
 
Collagen is the most abundant protein in the animal kingdom. It is often spoken of 
as a singular entity but collagen is actually a family of 20 proteins, all of which contain a 
repeating three amino acid motif of glycine, proline and a variable third amino acid. The 
variety of collagen proteins underscore its utility and importance but 80-90% of the 
collagen within the human body is comprised of types I, II and III. Hydrogen bonding 
between the glycine side chain and carbonyl group of the adjacent peptide allow collagen 
polymers to intertwine into triple helices. These helices then align into long fibrils which 
interconnect to produce the ECM see figure 2. 
 
 
 
Figure 2. The Structure of Collagen Macromolecules.  Collagen amino acid chains 
combine to a form triple helical procollagen structure. Cleavage of the N and C terminals 
produces the more water soluble Tropocollagen. Tropocollagen molecules are covalently 
bound to form fibrils which are the principal component of the ECM (fr.wikipedia, 2005). 
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Though extruded collagen proteins self assemble into fibrils, decellularized whole 
fibrils are non soluble. Collagen hydrogels often contain separate fibers which are then 
crosslinked once the hydrogel has been placed using temperature or pH gradients (Drury 
& Mooney, 2003). This study will focus on Type 1 collagen, specifically tropocollogen. 
Type 1 is the principal component of the skin and tropocollogen is more soluble than 
other collagen structures. Type I tropocollogen is the most used form of collagen 
hydrogel and also reflects the natural tissue. 
 
 
Polyesters 
 
Polyesters are polymers formed through condensation reactions between a 
carbonyl hydrogen of one molecule and a hydroxyl groups a second molecule. This 
creates an ester which links the two carbon chains, R-0-R. While polyesters have 
excellent biocompatibility and can be manipulated during synthesis to meet design 
specifications, their chief advantage is their biodegradability. Over time the esters will 
stochastically hydrolyze breaking the macromolecule down into component polymers. 
Most polyesters break down into units which are readily metabolized (Gunatillake & 
Adhikari, 2003). PLGA for example, hydrolyzes into lactic acid and glycolic acid which 
are readily metabolized by the body.  Because the units can be easily interchanged 
23 
 
polyesters are tunable, the length and number of units can be chosen for the tissue of 
interest. The ratio of lactic acid to glycolic acid in PLGA can be modified to affect a 
scaffold’s melting temperature, strength and degradation rate. Polyesters have already 
been used for FDA approved drug delivery devices.  Capronor for example, is an 
implanted birth control sub dermal PCL device which can be used to deliver 
levonorgestrel to a patient for a year (Armani & Liu, 2000).  
One drawback of polyesters is that they are relatively hydrophobic in a biological 
microenvironment. Scaffolds will often be functionalized with polar compounds such as 
ZnO to improve solubility. This contributed to the relative paucity of polyester hydrogels 
when compared to collagen hydrogels. This study was intended to focus exclusively on 
polycaprolactone scaffolds but the lack of suitable literature necessitated the broadening 
of the scaffolds utilized in this study. While this increased variability reduces the 
specificity of the findings it also broadens the application of the work making it more 
representative of the polyester family and scaffolds as a whole.   
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Chapter II 
Research Methods 
 
 
The methods for developing the cell survival calculator are outlined in this section. Data 
published in a previous works were used for modeling by regression analysis to identify 
the rate of wound repair.  The accuracy of the reepithelialization calculator was assessed 
by comparing the difference between expected values and those published. 
 
 
Selection Criteria 
 
This study will be focused on hydrogels applied to murine skin therapeutics 
utilizing collagen, polyester or hybrid collagen polyester cell scaffolds. These specific 
tissue engineering products were chosen because they will provide enough data for 
statistical analysis, while maintaining properties similar enough to compare across 
studies. Hydrogels are preferable to other tissue engineering applications as they will not 
be dependent on spatial structure or design. Identical compounds at uniform 
concentrations should behave identically across different studies. Hydrogels make 
excellent skin therapeutics because they are easily applied, can satisfy the tissues 
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structural requirements and can cover the affected area without concern for immediate 
engraftment with neighboring tissue. Murine animal models are often used to test 
preclinical skin therapeutics, providing a sufficient range of studies to meet the selection 
criteria. Additionally once therapeutics are defined as full or partial, skin treatments are 
in many ways two dimensional. Therapeutics applied to another organ would have a 
many spatial discrepancies between different applications.  Lastly, the three cell scaffold 
types were chosen to serve as representatives of natural, synthetic and composite cell 
scaffolds. Taken together these three scaffolds will represent the range of tissue 
engineering capabilities, from natural to synthetic compounds.  These scaffolds are 
widely used and will provide enough citations to build an effective algorithm while being 
representative of the larger cell scaffold population. 
 
 
Literature review and indexing 
 
Previous published studies will provide data for the cell scaffold survival 
calculator.  Studies will be limited to in vivo, hydrogel, cell scaffolds applied to rodents 
comprised of collagen, polyester or collagen-polyester composites scaffolds. Collagen 
and polyester are often used biomaterials and are suitable representatives of natural and 
synthetic scaffolds in general. Up to one hundred papers for each scaffold type will be 
utilized to provide a robust sample size for a training data set. Though all of the described 
metrics will not be included in the paper every effort will be made to select papers that 
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include quantitative measurements of all of the metrics described. Cell survival and 
infiltration information will be the most important metrics, papers which contain this data 
will be preferentially selected. Three scaffold types will help reduce bias, by comparing 
cell survival across different scaffolds it will be easier to determine baselines and thereby 
eliminate outliers. Relying on a single scaffold type could skew the data, 
overemphasizing a specific interaction between the biomaterial and the cells. Developing 
an index of the relationship between cell scaffold and biocompatibility in untreated 
scaffolds will represent the nominal survival rates. The material, fabrication method, 
porosity, concentration, cellular seeding density, cellular survival, cellular infiltration and 
the addition of any signaling molecules will be noted as reported quantitatively in each 
study. The purpose of the calculator put forward in this proposal is to predict the change 
in cellular survival for each unit change in these metrics. 
 
 
Regression Analysis of Reepithelialization 
 
Once indexed the metrics identified in part one of the methods will be utilized to 
develop statistical relationships between the scaffolds properties and cellular 
reepithelialization.  Qualitative factors will be compared by ANOVA and T-tests while 
quantitative factors will be compared by regression analysis. Linear models will be 
tested first but logarithmic, quadratic and exponential will also be reported so that a 
higher degree polynomial function would be identified in the event of a better statistical 
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fit.  Such multi order polynomials may not be amenable to the calculator being 
developed here but they would still provide information about the relationship of the 
metric with survival. The relationship between each metric and cell survival was 
visualized graphically and the statistical results were reported. Transformations and 
multiple models will be applied to identify the equation which best reflects the changes 
in cell survival.  The coefficients of each of these models will be used to develop the 
calculator. Confidence intervals for these calculations will be set at 95% and the p value 
threshold will be set at 0.05.  
 
ANOVA Analysis 
 
Once the initial regression model has been generated an analysis of variants 
(ANOVA) will be performed to answer two questions. First, it will identify which 
metrics have a significant effect on reepithelialization. The interaction between two 
variables must produce a p value <0.05 to be considered significant. Multiple iterations 
may be necessary to produce the model which best reflects the changes in cellular 
survival. The adjusted R square value, which is a measure of the relationships between 
variables in a multiple regression analysis will be utilized to rank the different iterations. 
The coefficients produced in the model with the highest R square value will used for the 
final calculator. ANOVA analysis will identify if any of the indexed metrics have a 
significant effect between each other. This is particularly important because it will 
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identify any multicollinearity, that is to say multiple metrics which produce the same 
effect in survival. Multicollinearity is quite possible as many of these metrics are 
interrelated at a physical level but may not share a correlative relationship. For example a 
scaffolds concentration and porosity may both be the result of type of cross-linking and 
hence be physically correlative but they could produce two different cellular responses. 
While many scaffolds can serve as drug delivery vehicles non biologics will not be 
considered for this thesis. The predictive power of each metric will be reported, any 
multicollinearity will be identified. 
 
 
Reepithelialization Accuracy Testing 
 
 
Ten additional studies for each type of scaffold will be used as a validation testing 
the accuracy of predicting cell survival. The expected survival as predicted by the 
calculator will be compared to the survival observed in the course of the study. 
Discrepancies could indicate a need to reformat the model, alternative models which 
were passed over in the course of modeling will be tested as well to identify unaccounted 
factors which do not fit the model. Remaining discrepancies between the calculator and 
the observed results after running through all of the parameters will indicate that the 
survival is being affected by an unreported metric. If the system is accurate variables 
such as the biomaterial and seeding density could be used to predict the cellular survival 
in a wide range of therapies using these scaffold types.   
29 
 
 
 
 
Chapter III 
 
Results 
 
 
 Data from 232 papers were successfully used to develop a cell scaffold calculator. 
Wound repair rates varied greatly both within and across classes of cell scaffolds. 
Expected results did not correlate with observed results reported with the test group of 
published papers. The major determinants of reepithelialization were not represented in 
this analysis.  
 
 
Study Summary 
 
Data from 232 papers were utilized in the generation of the cell scaffold calculator. As 
the papers often contained multiple scaffolds over the course of multiple time points this 
resulted in 1016 individual data points quantifying the reepithelialization of 444 cell 
scaffolds, as outlined in Table 3. Several journals contained more suitable studies than 
most other journals. Biomaterials, Burns, Tissue Engineering Part A, and Materials 
Science Engineering were often utilized, but a wide variety of journals were used as 
visualized in figures 3a-c. Journals which contributed only one paper were labeled as 
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other. The variety of journals and experiments limited the bias of any individual reporting 
system. 
Table 3 
Breakdown of Data Included in This Analysis. 
  Number 
of Papers 
Number of 
therapeutic tests 
Number of data 
points 
Natural Scaffolds 
(Collagen) 
100 196 438 
Synthetic Scaffolds 
(Polyesters) 
83 158 363 
Hybrid Scaffolds 
(Collagen-polyester 
hybrids) 
49 90 215 
Total 232 444 1016 
Note: The number of therapeutic tests includes both hydrogels and 
controls without therapeutics. The number of data points is the sum of 
reepithelialization measurements reported for all scaffolds. 
 
 
Figure 3a. Journals with Collagen Therapeutics Utilized in This Study. Of 100 papers 
reporting collagen therapeutics which were utilized in this study most were from Tissue 
Engineering Part A, Biomaterials and Burns.  
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Figure 3b. Journals with Polyester Therapeutics Utilized in This Study. Of 83 papers 
reporting collagen therapeutics which were utilized in this study most were from 
Biomaterials, The Journal of Biomedical Materials Research Part A and Materials and 
RSC Advances.  
 
 
Figure 3c. Journals with Collagen Polyester Therapeutics Utilized in This Study. Of 49 
papers reporting collagen therapeutics which were utilized in this study most were from 
Biomaterials, Tissue Engineering Part A and RCS Advances.  
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Though the information reported in journals varied, the most commonly used metric of 
survival was reepithelialization. This was quantified by the percentage change in area of 
the wound. For example a 4 cm
2
 wound that was reduced to 2 cm
2
 would be reported as 
50% healed. While some studies made use of immunohistochemistry, GFP producing 
seeder cells or cell proliferation assays these were the uncommon and in total constituted 
<12% of the total number of studies (see figure 4). Where possible metrics were 
converted to % wound healed if possible.  
 
 
 
 
 
Figure 4. Cellular survival metrics reported across all 232 papers. Papers reported on cell 
survival utilizing a variety of metrics, percent wound healed was the most often used 
metric. When possible metrics were converted to percent would healed to standardize 
comparisons. 
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Though there were slight differences across the scaffold classes, approximately 
2/3 of the studies utilized mice as the model organism. The remainder were performed in 
rats with the exception of two studies which used Guinea pigs (see figure 5). Within these 
species there were a variety of strains utilized such as BALB/C and Sprague Dawley.  
 
 
 
Figure 5. Model Animals Used Across All Three Scaffold Classes. Most experiments 
were performed in mice.  
 
 
Collagen cell scaffolds were most often obtained by decellularizing bovine, 
porcine or rat tissues. Some studies only listed where the collagen was purchased from 
rather than how it was generated. These studies focused on Collagen I so it is likely that 
these materials were also derived from decellularized animal tissue.  Synthetic and hybrid 
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scaffolds were most often produced by electrospinning solutions of collagen and 
polyesters (See figures 6a-c). These studies represent a wide variety of scaffold 
formulations while adhering to the criteria set forth.  The wide range of experimental 
conditions most likely minimized the chance of sampling bias. The synthetic and hybrid 
scaffolds were comprised of a variety of polyesters (see  figure 7). 
 
 
 
Figure 6a. Fabrication Methods of Collagen Cell Scaffolds. Most collagen cell scaffolds 
were produced from decellularized animal tissue. The donor tissues varied greatly 
including bovine skin, rat tail and jellyfish tissue. 
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Figure 6b. Fabrication Methods of Polyester Cell Scaffolds. Most polyester scaffolds 
were produced by electrospinning.  
 
 
 
Figure 6c Fabrication Methods of Polyester Collagen Cell Scaffolds. Most polyester 
collagen scaffolds were produced by electrospinning.  
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Figure 7 Scaffolds By Polyester Type. A diverse selection of aliphatic homopolymers 
were utilized for the synthetic scaffolds. 
Wound Healing 
 
As discussed above, percent of the wound which had reepithelialized was the 
most often reported metric in papers reporting epidermal scaffold therapeutics. Though 
this is not a distinct metric of survival it is indicative of the fact that cells are surviving 
within the scaffold. As most studies reported the percent of the wound that was repaired 
over several time points the metric was best visualized as a dot plot over time, (see figure 
8).  
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Figure 8. Percent of Wound Repaired vs. Time in Hours by Scaffold Class. The wound 
repair rate varied greatly both within and across scaffold classes. The best fit lines had the 
following slopes and goodness of fit, Hybrid (S=0.02, r
2
=0.034), Natural  (S=0.03, 
r
2
=0.066)   Synthetic  (S=0.06, r
2
=0.171). 
 
 
The slope of the regression curve here is equal to the percentage healing that occurs per 
hour. All three scaffold classes display a clear increase in the amount of wound that was 
repaired over time, though the goodness of fit is always below 0.25 indicating a wide 
variance in the amount of healing that occurs across studies.  
This discrepancy is not completely unexpected, wound dermal repair often 
accelerates over time and the calculation for percent wound repair is based off of the 
initial wound size. Reepithelialization will naturally accelerate as the wound’s perimeter 
decreases. But it is still important to understand if these differences are driven my 
experimental conditions or by the natural processes. The goodness of fit is improved by 
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switching to a log scale or an exponential regression curve which would better model the 
acceleration in repair, but the data still indicates that the healing within different studies 
occurs at different rates (see figure 9). Quadratic and polynomial equations did not fit the 
data well and were excluded from analysis (data not shown). 
 
 
 
Figure 9. Percent of Wound Repaired vs. Time in Hours by Scaffold Class with 
Logarithmic Regression. The goodness of fit between time and percent of wound healed 
improved slightly with a logarithmic curve rather than the linear scale in Figure 8. The 
best fit lines had the following slopes and goodness of fit, Hybrid (S=0.14, r
2
=0.38), 
Natural  (S=0.25, r
2
=0.088)   Synthetic  (S=0.5, r
2
=0.299). 
 
To gain a more refined view the healing rate was calculated for individual scaffolds in 
which the study reported the percent that the wound was repaired over multiple time 
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periods. The healing rate is still equivalent to percent of skin repaired per hour but limited 
to a specific scaffold (see figure 10). 
 
Figure 10. Healing Rate by Study number and scaffold. The healing rates varied even 
between similar scaffolds applied in the same experiment.  
 
 
Further subdividing by study numbers shows that the healing rate can vary greatly 
between scaffolds reported in the same paper which were applied to identical animal 
cohorts (data not shown). This indicates that the differences in healing are due to 
experimental conditions rather than biological conditions. It’s further worth noting that 
many of these scaffolds are facilitating healing at a rate greater than the 5%-10%/day, 
(0.2%-0.4% wound healing/hour),  observed in small scale human dermal repair (FRS, 
1993). 
 Lastly the healing rate was compared to the initial surgical area to identify any 
bias due wound size. One would expect that smaller wounds can be more easily repaired 
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by the animal’s innate regenerative capacity thus representing a smaller contribution from 
the therapeutic. 
 
 
 
Figure 11. Healing Rate by Surgical Area. Larger surgical area had a weakly positive 
correlation with healing rate but the relationship is not strong, the goodness of fit was 
0.002. The best fit line equation sope is 0.04 and the r
2
=0.001 . 
 
 
Surprisingly, there is little relationship between the area of the wound and the rate 
of healing (see figure 11). This may indicate that the wounds were so small that the skin 
would have naturally regenerated without additional aid. Dermal wounds are often 
broken down into two categories, those that are small enough to reepithelialize into 
dermis and those that are too large to heal properly, resulting in scars (FRS, 1993). These 
wound models most closely mimicked smaller wounds which would have healed with 
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minimal scar tissue. The therapeutics may be more effective at promoting wound repair 
to avoid infection rather than instigating exceptional regeneration that the body could not 
have performed itself 
Cell scaffold properties which influence wound healing. 
 
 
The class of cell scaffold was shown to have little impact on the healing rates in natural 
or hybrid scaffolds but it was shown to be slightly higher in synthetic polyester scaffolds. 
This difference is statistically significant with a P Value <0.001, indicating that synthetic 
scaffolds heal faster than hybrid or natural scaffolds (see figure 12 below and Table 11 in 
the appendix).  
Fabrication method also influenced the rate of healing, electrospun scaffolds were 
shown to heal faster than the natural, decellularized scaffolds. These differences were 
shown to be significant with P values below 0.0001 (see figure 13 below and Table 12 in 
the appendix). Some fabrication methods such as collagen obtained by cell culture 
extrusion were used rarely, N=2. These methods were not considered in further analysis 
as there is too little data to make  
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Figure 12. Healing Rate by Scaffold Class. There was no statistical difference in the 
healing rate of hybrid and natural scaffolds, synthetic scaffolds had higher healing rates 
than the other two scaffold classes, this difference was found to be statistically significant 
by ANOVA (see table 11).  
 
 
 
Figure 13. Healing Rate Across Scaffold Fabrication Methods. Only electrospun 
scaffolds had  significantlysignificant higher healing rates than the other fabrication 
methods when analyzed by ANOVA (see table 12 in the appendix). 
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The amount of cell seeding was shown to impact the scaffolds healing rate. Direct 
comparisons between seeded and unseeded scaffolds show that the median healing rate 
for seeded scaffolds is higher than that of unseeded scaffolds. This difference is 
statistically significant with a P value <0.0001, (see figure 14). 
 
 
 
Figure 14. Healing Rates Between Seeded and Unseeded Scaffolds. Seeded scaffolds 
were had higher healing rates when compared to unseeded scaffolds by a T-test. 
 
 
Lastly, the rate of wound healing was compared to the amount of cells included with the 
scaffold. Higher quantities of cells produce a higher healing rate (see figure 15).  
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Figure 15. Healing Rate by Number of Seeded Cells. The number of seeded cells was 
found to positively correlate with the scaffolds healing rate across all three scaffold types 
but the goodness of fit was relatively small,  r
2
=0.216. 
 
 
Together this data indicates that, polyester, electrospun seeded, scaffolds all have 
higher levels of wound healing and the amount of cells seeded with the scaffold is 
proportional with the healing rate. However, there is one group of experiments which 
may skew this data. Some polyester scaffolds have abnormally high healing rates. These 
studies all contained early measurements, performed within the first 48 hours, during 
which time there was minimal wound repair, the typical levels of reepithelialization from 
later time points are exaggerated by comparison. This likely increased the slope of the 
wound repair resulting in a higher healing rate without an actual increase in 
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reepithelialization. Because the majority of the cells which are electrospun are polyester 
this group probably skewed both the comparison across scaffold class and fabrication 
method. Nonetheless, without a biological reason to exclude these data points they were 
included in further analysis. 
 
Generation of a Tissue Engineering Reepithelialization Calculator 
 
 To operate the reepithelialization calculator users input the type of scaffold in 
question, the fabrication method, and the amount of cells added, number of days since 
application and the initial wound size. The calculator is based off of the log based 
equations relating days of scaffold application and wound size as seen in figure 10. 
Remaining in log space more accurately predicts the exponential healing rate of natural 
wound repair, namely a slow rate of repair in the first few days followed by an increasing 
rapid closure as the wound area decreases. By solving for Y these equations produce the 
percentage of area which should be reepithelialization by the scaffold class at a given 
time. 
                               
Where WR equals wound repair, A equals the y intercept, B equals the slope of 
the line (the rate of reepithelialization), and X equals the time since the therapeutic was 
applied in hours. Having calculated the percent of wound repair the effect of the 
fabrication is then calculated. The effect of fabrication was calculated using the healing 
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rate, or percent of the wound healed per hour, (see Table 12 in the appendix, page 98). 
The difference between the average amount of wound repair and the affect of the 
fabrication can be added to the % wound repair calculated above. The values for each 
scaffold class are displayed in Table 4 below. 
 
 
Table 4 
Rate of reepithelialization by scaffold 
type 
A is the Y intercept and B is the 
percentage of wound healed per hour, 
both by scaffold type. 
  A B 
Natural Scaffolds 
(Collagen) 
0.94 0.24 
Synthetic 
Scaffolds 
(Polyesters) 
0.52 0.51 
Hybrid Scaffolds 
(Collagen-
polyester 
hybrids) 
0.98 0.28 
 
 
Affect of fabrication      
  
  
                     
  
  
  
      d 
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 Where WR equals wound repair, AH equals the area healed, AI equals the area injured 
and TH equals the time healed. As only electrospun scaffolds have been found to deviate 
from the average wound repair rate natural scaffolds do not need to be taken into account. 
                   Wound rate of electrospun scaffolds- Average Wound rate  
The effect of cell seeding was already calculated as a continuous variable using linear 
regression comparing the time since therapeutic application in hours and the healing rate, 
see figure 15. As with the effect of fabrication this number can be multiplied by the time 
since application in hours and added to the previous measurements. Taking the sum of all 
three metrics produces the final % of wound which has been healed. 
                                   
Where SSWR equals the scaffold specific wound repair, WRF equals the wound repair 
from fabrication and WRCS equals the wound repair from cell seeding. 
 
Wound Reepithelialization Calculator Precision 
 
Ten papers for each of the scaffold classes were randomly selected to serve as a 
test data set so that the precision of the wound reepithelialization calculator could be 
assessed. The calculator was a poor predictor of actually reepithelialization, the 
difference between expected and observed results could vary as much as 40%. The 
goodness of fit across the different scaffold classes was ordered identically to goodness 
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of fit calculated for the rate of wound healing computed in the initial data set. Polyester 
scaffolds were most closely related to their expected reepithelialization rates (R
2
=0.151) 
than collagen polyester (R
2
= 0.096) or collagen (R
2
= 0.003) scaffolds. It is likely that the 
variance seen in both test sets is indicative of inherent variance in the scaffold class.  
 
 
 
Figure 16. Cell Scaffold Reepithelialization Precision Comparison. The 
reepithelialization had little concordance between expected and observed wound repair. 
The best fit lines had the following slopes and goodness of fit, Collagen (S=0.11, 
r
2
=0.003), Collagen Polyester  (S=0.43, r
2
=0.096)   Polyester  (S=0.53, r
2
=0.151). 
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The cell scaffold reepithelialization calculator is available for public use at 
https://drive.google.com/open?id=0B2qtpQ_lfNl8SHBFbjZwaTBSSUE. 
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Chapter IV 
Discussion 
 
 
 After comparing data from over 400 scaffolds the dermal reepithelialization 
calculator was unable to accurately predict the reepithelialization rates for the 30 test 
studies. There is little comparison to be made across these different therapeutics other 
than that the amount of healing increased over time. Healing rates and levels seem to be 
vastly different across scaffolds and studies. This discrepancy could come from several 
sources. First the scaffold metrics examined in this study may not have been the most 
important factors in wound repair. There are many factors which are known to influence 
cell-surface interactions which were not reported here, tensile strength, contact angle, 
stiffness, and purity to name a few. More broadly, many of the studies did not report 
basic information which would be helpful in understanding the scaffolds that were 
utilized. For example many failed to discuss the size of the wound produced in the 
animals. Comparing across one of these unaccounted metrics may produce an unobserved 
symmetry.  
The second option is that there is some additional factor producing discrepant 
results that is only apparent when compared across scaffolds. Most studies only compare 
the scaffold of interest to a negative control animal model without any additional 
standard. Perhaps there is some condition which is cofounding wound repair but is not a 
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part of normal reporting and QC. One such factor could be the scaffold source. Collagen 
scaffolds in particular are taken from different tissues (rat tail, intestine, cadaverous skin), 
from different subjects and ages, yet they are treated as identically. We know that cells 
respond differently in such a wide range of tissues so it follows that wound repair would 
operate differently in such different scaffolds. This could be one reason why the collagen 
scaffolds were found to be the most discrepant. It could be that the natural scaffolds are 
inherently more complex and diverse than the artificial polyester scaffolds or the 
intermediate composite scaffolds.  
The third possible explanation is that the wound repair that is being observed is 
chiefly due to the animal model and the contributions of the scaffold are positive but 
minimal. This is supported by considering how long a biodegradable scaffold could have 
an effect. Some studies have indicated that as little as 3% of the collagen scaffold may be 
intact after 14 days in vivo (Helary et al., 2010). Many of the scaffolds utilized in this 
paper have less than 50% reepithelialization by this point so if a scaffold has had an 
effect it would have needed to occur during the initial wound stabilization and 
inflammation period.  ECM remodeling is a key feature in the repair pathways of host 
tissue, collagen scaffolds would be especially vulnerable to the expressed MMPs and 
their inhibitors, TIMPs. This line of questioning implicitly challenges the roll of a cell 
scaffold. The tissue engineering triad has a tacit assumption that a scaffolds role is to 
provide a foundation for the cells until the host tissue is able to complete repairs. A better 
perspective may be that a cell scaffold is most efficacious as a homeostatic stabilizer 
rather than an actual tissue. 
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The animals and cells used in these papers also varied greatly strain, age, wound 
location and animal health would all be expected to impact the rate of wound repair. 
Similarly the cell passage number, culture medium and handling would impact the 
survival and durability of seeded cells. Large scale studies have already demonstrated 
that rodent models can produce vastly different results than human studies which may 
speak to why many of these therapeutics did not progress to clinical use (Perel et al., 
2007; Seok et al., 2013).   
 While the imprecision of the reepithelialization calculator limit the scope of 
conclusions to the studies discussed it does emphasize the need for greater 
standardization. Without common results it is impossible to optimize design or 
selectively choose the scaffold for the tissue and need. The gap between laboratory tissue 
engineering therapeutics and clinical tissue engineering therapeutics is often discussed. 
This work outlines one contributing factor. The lack of relationships between similar 
therapeutics limits the utility of any given study, effectively making each scaffold an 
isolated N of one. Future work in tissue engineering would be greatly enhanced by 
shifting the paradigm away from one of experiments toward a unified system of 
evaluation. 
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Appendix 
 
 
Additional Tables 
 
Table 2 
The ECM vs. Cell Scaffolds During the Repair Process.   
Stages of wound repair by cellular matrix type. 
  1. Homeostatic 
Disruption 
2. Inflammatory 
Response 
3. Repair 4. Remodeling 
ECM 
contribution 
The ECM 
binds platelets 
blocking 
pathogens and 
preventing 
blood loss. 
ECM disruption 
amplifies the 
inflammatory 
response 
Extruded ECM 
stabilizes the 
wound allowing 
for cells such as 
keratinocytes  in 
the skin to move 
in and  fill the 
abscess.  
The ECM is 
realigned after 
the less 
regulated 
extrusion 
which occurred 
during the 
repair process.  
Cell 
Scaffold 
Contribution 
The body's 
initial 
response to 
damage, cell 
scaffolds are 
rarely applied 
at this stage of 
wound repair. 
Cell Scaffolds 
can stabilize the 
wound limiting 
excessive 
inflammation 
and fibrosis. 
The ability of the 
cell scaffold to 
recruit cells for 
repair is crucial for 
enhanced wound 
repair.  (N. -T. 
Dai, Williamson, 
Khammo, Adams, 
& Coombes, 2004)  
A scaffolds 
ability to 
remodel 
influences the 
amount of 
fibrosis and 
scaring. (Rosso 
et al., 2005) 
Note: Information compiled from Stroncek et al. unless otherwise noted (Stroncek & 
Reichert, 2008). 
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Published data used for analysis 
Table 5 
Papers with Collagen Scaffolds Used for Analysis.  
  Paper Name First Author Journal Year Reference 
1 
Evaluation 
of a multi-
layer 
adipose-
derived 
stem cell 
sheet in a 
full-
thickness 
wound 
healing 
model Yen-Chih Lin Acta Biomateriala 2013 
 (Lin et 
al., 2013) 
2 
Improved 
cellularizati
on and 
angiogenesi
s using 
collagen 
scaffolds 
chemically 
conjugated 
with 
vascular 
endothelial 
growth 
factor Qifen He Acta Biomaterialia 2011 
 (He et al., 
2011) 
3 
The roles of 
knitted 
mesh-
reinforced 
collagen-
chitosan 
hybrid 
scaffold in 
the one-step 
Wang 
Xingang Acta Biomaterialia 2013 
 (Xingang 
Wang et 
al., 2013) 
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repair of full 
thickness 
skin defects 
in rats 
4 
Thiol-ene 
Michael-
type 
formation of 
gelatin/poly(
ethylene 
glycol) 
giomatrices 
for three-
dimensional 
mesenchym
al 
stromal/ste
m cell 
administrati
on to 
cutaneous 
wounds Kedi Xu Acta Biomaterialia 2013 
  (Xu et 
al., 2013) 
5 
Enhancing 
repair of 
full-
thickness 
excisional 
wounds in a 
murine 
model: 
Impact of 
tissue-
engineered 
biological 
dressings 
featuring 
human 
differentiate
d 
adipocytes. 
Pascal 
Morissette 
Martin Acta Biomaterialia 2015 
 (Morisset
te Martin 
et al., 
2015) 
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6 
Engineering 
a 
vascularized 
collagen-β-
tricalcium 
phosphate 
graft using 
an 
electrochem
ical 
approach  
Yunqing 
Kang Acta Biomaterialia 2015 
 (Y, N, A, 
J, & Y, 
2015) 
7 
A novel 
hydrogel-
collagen 
composite 
improves 
functionality 
of an 
injectable 
extracellular 
matrix R. hartwell Acta Biomaterialia 2011 
 (Hartwell 
et al., 
2011) 
8 
Evaluation 
of 
Commonly 
Used 
Temporary 
Skin 
Dressings 
and a Newly 
Developed 
Collagen 
Matrix for 
Treatment 
of 
Superficial 
Wounds Manuel Held 
Advances in Skin & 
Wound Care 2015 
 (Held et 
al., 2015) 
9 
Effects of 
Human 
Adipose-
derived 
Stem cells 
on 
Cutaneous 
Wound 
Healing in Seung Ho Lee 
Annals of 
Dermatology 2011 
 (S. H. 
Lee, Lee, 
& Cho, 
2011) 
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Nude Mice 
10 
Efficacy of 
Novel 
Collagen/Ge
latin 
Scaffold 
with 
Sustained 
Release of 
Basic 
Fibroblast 
Growth 
Factor for 
Dermis-like 
Tissue 
Regeneratio
n 
Norikazu 
Kanda 
Annals of Plastic 
Surgery 2012 
 (Kanda et 
al., 2012) 
11 
Accelerated 
Wound 
Healing in 
Healing-
Impaired 
db/db Mice 
by 
Autologous 
Adipose 
Tissue-
Derived 
Stromal 
Cells 
Combined 
With 
Atelocollage
n Matrix 
Masaki 
Nambu 
Annals of Plastic 
Surgery 2009 
 (Nambu 
et al., 
2009) 
12 
Use of 
Porcine 
Acellular 
Dermal 
Matrix as a 
Anil 
Srivastava Annals of Surgery 2001 
 (Anil 
Srivastava 
et al., 
2001) 
58 
 
Dermal 
Substitute in 
Rats 
13 
Cultured 
Skin 
Substitutes 
Reduce 
Donor Skin 
Harvesting 
for Closure 
of Excised, 
Full-
Thickness 
Burns 
Steven T 
Boyce Annals of Surgery 2011 
  
(Desimon
e et al., 
2011) 
14 
In vitro 
Studies and 
Preliminary 
In vivo 
Evaluation 
of Silicified 
Concentrate
d Collagen 
Hydrogels 
Martin F. 
Desimone 
Applied Materials & 
Interfaces 2011 
 (Desimon
e et al., 
2011) 
15 
Improvemen
t in wound 
healing by a 
novel 
synthetic 
collagen-gel 
dressing in 
genetically 
diabetic 
mice Dichi Chikazu 
Asian Journal of Oral 
and Maxillofacial 
Surgery 2010 
 (Chikazu 
et al., 
2010) 
16 
Fabrication, 
quality 
assurance, 
and 
assessment 
of cultured 
skin 
substitutes 
for 
treatment of 
skin wounds 
Steven T 
Boyce 
Biochemical 
Engineering Journal 2004 
 (Steven T 
Boyce, 
2004) 
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17 
Injectable 
and 
Thermosens
itive Soluble 
Extracellula
r Matrix and 
Methylcellul
ose 
Hydrogels 
for Stem 
Cell 
Delivery in 
Skin 
Wounds Eun Ji Kim Biomacromolecules 2016 
 (E. J. 
Kim, 
Choi, 
Kim, 
Choi, & 
Cho, 
2016) 
18 
Developmen
t of N,O-
(Carboxyme
thyl)chitosa
n/Collagen 
Matrixes as 
Wound 
Dressing 
Ray-Neng 
Chen Biomacromolecules 2006 
 (R.-N. 
Chen, 
Wang, 
Chen, Ho, 
& Sheu, 
2006) 
19 
Influence of 
electrospun 
collagen on 
wound 
contraction 
of 
engineered 
skin 
substitutes 
Heather 
Powell Biomaterials 2008 
 (Powell, 
Supp, & 
Boyce, 
2008) 
20 
In 
vitro constit
ution and in 
vivo implant
ation of 
engineered 
skin 
constructs 
with sweat 
glands Sha Huang Biomaterials 2010 
 (Huang, 
Xu, Wu, 
Sha, & Fu, 
2010) 
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21 
A denatured 
collagen 
microfiber 
scaffold 
seeded with 
human 
fibroblasts 
and 
keratinocyte
s for skin 
grafting Margit Kempf Biomaterials 2011 
 (Kempf et 
al., 2011) 
22 
Enhanceme
nt of 
mesenchym
al stem cell 
angiogenic 
capacity and 
stemness by 
a 
biomimetic 
hydrogel 
scaffold 
Kristine 
Rustad Biomaterials 2012 
 (Rustad et 
al., 2012) 
23 
Expansion 
and delivery 
of human 
fibroblasts 
on 
micronized 
acellular 
dermal 
matrix for 
skin 
regeneration 
Xiaojun 
Zhang Biomaterials 2009 
 (X. 
Zhang et 
al., 2009) 
24 
Collagen 
scaffolds 
derived 
from a 
marine 
source and 
their 
biocompatib
ility Eun Song Biomaterials 2006 
 (Song, 
Yeon 
Kim, 
Chun, 
Byun, & 
Lee, 2006) 
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25 
Tissue-
engineered 
dermo-
epidermal 
skin grafts 
prevasculari
zed with 
adipose-
derived cells 
Agnieszka 
Klar Biomaterials 2014 
 (Klar et 
al., 2014) 
26 
The effect 
of cross-
linking of 
collagen 
matrices on 
their 
angiogenic 
capability Chang Yao Biomaterials 2008 
 (Yao, 
Markowic
z, Pallua, 
Noah, & 
Steffens, 
2008) 
27 
Promoted 
growth of 
murine hair 
follicles 
through 
controlled 
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endothelial 
growth 
factor Makoto Ozeki Biomaterials 2002 
 (Ozeki & 
Tabata, 
2002) 
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promoted 
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follicles by 
the 
controlled 
release of 
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factors Makoto Ozeki Biomaterials 2003 
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Mitigation 
of 
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Elizabeth R. 
Lorden Biomaterials 2015 
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2015) 
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biodegradab
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Towards 
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healing 
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Garcia Biomaterials 2008 
 (Garcia, 
Wilkins, 
Collighan, 
Griffin, & 
Pandit, 
2008) 
31 
The 
Influence of 
Pancreas-
derived 
stem cells 
on scaffold 
based skin 
regeneration H. Salem Biomaterials 2009 
 (Salem et 
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75 
Integrated  poly-
D,L-lactide-co-
glycolide/silver 
nanocomposite: 
synthesis, 
characterization and 
wound healing 
potential in Wistar 
Albino rats. 
Renu 
Sankar RSC Advances 2016 
 (Sankar, 
Shivasha
ngari, & 
Ravikum
ar, 2016) 
76 
Ibuprofen loaded 
PLA nanofibrous 
scaffolds increase 
proliferation of 
human skin cells in 
vitro and promote 
healing of full 
thickness incision 
wounds in vivo 
M. Mohiti-
Asli 
Society For 
Biomaterials 2017 
 (Mohiti-
Asli et 
al., 2017) 
77 
Vitalization of 
Porous Polyethylene 
(Medpor) with 
Chondrocytes 
Promotes Early 
Implant 
Vascularization and 
Incorporation into 
the Host Tissue 
Susanne 
Ehrmantrau
t 
Tissue Engineering 
Part A 2012 
 (Ehrmant
raut et al., 
2012) 
78 
Biocompatible 
Nanofiber Matrices 
for the Engineering 
of a Dermal 
Substitute for Skin 
Regeneration 
J. 
Venugopal Tissue Engineering 2005 
 (Venugo
pal & 
Ramakris
hna, 
2005) 
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79 
A Rapid Fabricated 
Living Dermal 
Equivalent for Skin 
Tissue Engineering: 
An In Vivo 
Evaluation in an 
Acute Wound Model 
Michael 
Ananta 
Tissue Engineering 
Part A 2011 
 (Michael 
Ananta et 
al., 2011)  
80 
Vascularization of 
the Dermal Support 
Enhances Wound 
Re-Epithelialization 
by In Situ Delivery 
of Epidermal 
Keratinocytes 
Liana M. 
Lugo 
Tissue Engineering 
Part A 2010 
 (Lugo, 
Lei, & 
Andreadi
s, 2010) 
81 
Effect of artificial 
dermal substitute, 
cultured 
keratinocytes and 
split thickness skin 
graft on wound 
contraction 
Michael J. 
Reid 
Wound Repair and 
Regeneration 2007 
 (Reid, 
Currie, 
James, & 
Sharpe, 
2007) 
82 
Androgen actions in 
mouse wound 
healing: Minimal in 
vivo effects of local 
antiandrogen 
delivery 
Yiwei 
Wang 
Wound Repair and 
Regeneration 2016 
 (Yiwei 
Wang et 
al., 2016) 
83 
Histological 
evaluation of skin 
reconstruction using 
artificial dermis Matsui R. Biomaterials 1996 
 (Matsui 
et al., 
1996) 
 
 
 
 
Table 7 
Papers With Polyester Collagen Scaffolds Used in This Analysis 
1 
Nanofibrous 
rhPDGF-eluting 
PLGA-collagen 
hybrid scaffolds 
enhance healing of Chen-Hung Lee RCS Advances 2016 
 (C.-H. 
Lee et 
al., 
2016) 
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diabetic wounds 
2 
Rapid creation of skin 
substitutes from 
human skin cells and 
biomimetic 
nanofibers for acute 
full-thickness wound 
repair 
Sayed Babak 
Mahjour  Burns 2015 
 (Mahj
our et 
al., 
2015) 
3 
Effects of 
nanofiber/Stem cell 
composite on wound 
healing in Acute Full-
Thickness Skin 
Wounds Kun Ma 
Tissue 
Engineering 
Part A 2011 
 (Ma et 
al., 
2011) 
4 
The roles of knitted 
mesh-reinforced 
collagen-chitosan 
hybrid scaffold in the 
one-step repair of full 
thickness skin defects 
in rats Wang Xingang 
Acta 
Biomaterialia 2013 
 (Xing
ang 
Wang 
et al., 
2013) 
5 
PLLA-collagen and 
PLLA-Gelatin Hybrid 
scaffolds with funnel-
like porous structure 
for skin tissue 
engineering Hongxu Lu 
Science and 
Technology of 
Advanced 
Materials 2012 
 (Lu et 
al., 
2012) 
6 
Augmentation of 
diabetic wound 
healing and 
enhancement of 
collagen content 
using nanofibrous 
glucophage-loaded 
collagen/PLGA 
scaffold membranes Cheng-Hung Lee 
Journal of 
Colloid and 
Interface 
Science 2015 
 (C.-H. 
Lee et 
al., 
2015) 
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7 
Mitigation of 
hypertrophic scar 
contraction via an 
elastomeric 
biodegradable 
scaffold 
Elizabeth R. 
Lorden Biomaterials 2015 
 (Lord
en et 
al., 
2015) 
8 
In vitro and in vivo 
evaluation of the 
wound healing 
capability of 
electrospun 
gelatin/PLLCL 
nanofibers Guorui Jin 
Bioactive and 
Compatible 
Polymers 2014 
 (Jin, 
Li, 
Prabha
karan, 
Tian, 
& 
Ramak
rishna, 
2014) 
9 
An elctrospun 
scaffold with anti-
androgen receptor 
compound for 
accelerating wound 
healing Cassandra Chong 
Burns & 
Trauma 2013 
 (Chon
g, 
Wang, 
Maitz, 
Siman
ainen, 
& Li, 
2013) 
10 
Functionalisation and 
surface modification 
of electrospun 
polylactic acid 
scaffold for tissue 
engineering Elham Hoveizi 
Cell Biology 
International 2014 
 (Hove
izi, 
Nabiu
ni, 
Parivar
, 
Rajabi
-Zeleti, 
& 
Tavak
ol, 
2014) 
11 
A new, bioactive 
antibacterial-eluting, 
composite graft for 
infection-free wound 
healing. Anupama Mittal 
Wound Repair 
and 
Regeneration 2014 
 (Mitta
l & 
Kumar
, 2014) 
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12 
Engineered human sk
in fabricated using ele
ctrospun collagen-
PCL blends: 
morphogenesis and 
mechanical 
properties. 
 Heather Powell 
Wound Repair 
and 
Regeneration 2015 
 (Powe
ll & 
Boyce, 
2009) 
13 
An Investigation 
Study of Gelatin 
release from semi-
interpenetrating 
polymeric network 
hydrogel patch for 
excision wound 
healing on Wistar rat 
model. Maneesh Jaiswal 
Journal of 
Applied 
Polymer 
Science 2014 
 (Jaisw
al, 
Gupta, 
Dinda, 
& 
Koul, 
2015) 
14 
Microporous Dermal-
Like Electrospun 
Scaffolds Promote 
Accelerated Skin 
Regeneration Paul Bonvallet 
Tissue 
Engineering: 
Part A 2014 
 (Bonv
allet et 
al., 
2014; 
“Micro
porous 
Derma
l-Like 
Electro
spun 
Scaffol
ds 
Promo
te 
Accele
rated 
Skin 
Regen
eration
,” 
2014) 
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15 
The healing effect of 
unrestricted somatic 
stem cells loaded in 
collagen- modified 
nanofibrous PHBV 
scaffold on full-
thickness skin defects 
Saeed Heidari 
Keshel 
Artificial Cells, 
Nanomedicine 
and 
Biotechnology 2014 
 (Kesh
el et 
al., 
2014) 
16 
In vitro and in 
vivo evaluation of 
electrospun 
nanofibers of PCL, 
chitosan and gelatin: 
A comparative study S.R. Gomes 
Materials 
Science and 
Engineering: C 2015 
 (Gom
es et 
al., 
2015) 
17 
Multilayer Cell-
Seeded Polymer 
Nanofiber Constructs 
for Soft-Tissue 
Reconstruction Daniel Barker 
JAMA 
Otolaryngology 
Head & Neck 
Surgery 2013 
 (Bark
er et 
al., 
2013) 
18 
Small-diameter 
biodegradable 
scaffolds for 
functional vascular 
tissue engineering in 
the mouse model Jason Roh Biomaterials 2008 
 (Roh 
et al., 
2008) 
19 
Human single-donor 
composite skin 
substitutes based on 
collagen and 
polycaprolactone 
copolymer Niann-Tzyy Dai 
Biochemical 
and Biophysical 
Research 
Communication
s  2009 
(Niann
-Tzyy 
Dai et 
al., 
2009) 
20 
Biocompatible 
Nanofiber Matrices 
for the Engineering of 
a Dermal Substitute 
for Skin Regeneration J. Venugopal 
Tissue 
Engineering 2005 
 (Venu
gopal 
& 
Ramak
rishna, 
2005) 
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21 
Improving the Cell 
Distribution in 
Collagen-coated 
Poly-Caprolactone 
Knittings Weilum Sun 
Tissue 
Engineering 
Part C: Methods 2012 
 (Sun 
et al., 
2012) 
22 
A Poly(Lactic Acid-
Co-Caprolactone)-
Collagen Hybrid for 
Tissue Engineering 
Applications M. Ananta 
Tissue 
Engineering 
Part A 2008 
 (M. 
Ananta 
et al., 
2008) 
23 
The three-
dimensional 
vascularization of 
growth factor-
releasing hybrid 
scaffold of poly (E-
caprolactone)/collage
n fibers and 
hyaluronic acid 
hydrogel Ekaputra AK Biomaterials 2011 
 (Andr
ew K. 
Ekaput
ra, 
Prestw
ich, 
Cool, 
& 
Hutma
cher, 
2011) 
24 
Collagen surface 
modified poly (E-
caprolactone) 
scaffolds with 
improved 
hydrophilicity and 
cell adhesion 
properties Ines Sousa 
Materials 
Letters 2014 
 (Sous
a, 
Mende
s, 
Pereira
, & 
Bártol
o, 
2014) 
25 
A novel poly (L-
lactide-co-e-
caprolactone) 
Collagen hybrid 
construct for 
application in tissue 
engineering M. Ananta TERMIS-EU 2007 
 (M. 
Ananta
, 
Hilbor
n, 
Aibibu
, 
Brown
, & 
Muder
a, 
2007) 
104 
 
26 
Spatial Arrangement 
of 
Polycaprolactone/Col
lagen Nanofiber 
Scaffolds Regulates 
the Wound Healing 
Related Behaviors of 
Human Adipose 
Stromal Cells Fu X. 
Tissue 
Engineering 
Part A 2011 
 (X. Fu 
& 
Wang, 
2011) 
27 
In vivo 
biocompatibility of 
collagen 
poly(hydroxyethylme
thacrylate) hydrogels Jeyanthi R. Biomaterials 1990 
 (Jeyan
thi & 
Pandur
anga 
Rao, 
1990) 
28 
In vivo promoted 
growth of mice hair 
follicles by the 
controlled release of 
growth factors Ozeki M Biomaterials 2003 
 (Ozek
i & 
Tabata
, 2003) 
29 
Initial experience 
with a composite 
autologous skin 
substitute 
Robert L. 
Sheridan Burns 2001 
 (Sheri
dan et 
al., 
2001) 
30 
Markers to Evaluate 
the Quality and Self-
Renewing Potential 
of Engineered Human 
Skin Substitutes In 
Vitro and after 
Transplantation Pontiggia L. 
Journal of 
Investigative 
Dermatology 2009 
 (Ponti
ggia et 
al., 
2009) 
31 
Effect of Poly (3-
hydroxybutyrate-co-
3-hydroxyvalerate) 
Nanofiber Matrices 
Cocultured With Hair 
Follicular Epithelial 
and Dermal cells for 
Biological Wound 
Dressing Insook Han 
Artificial 
Organs 2007 
 (Han 
et al., 
2007) 
105 
 
32 
Electrospun 
PLGA/collagen 
nanofibrous 
membrane as early-
stage wound dressing Shih-Jung Liu 
Journal of 
Membrane 
Science 2010 
 (S.-J. 
Liu et 
al., 
2010) 
33 
Collagen hydrogels 
strengthened by 
biodegradable meshes 
are a basis for dermo-
epidermal skin grafts 
intended to 
reconstitute human 
skin in a one-step 
surgical intervention 
Fabienne 
Hartmann-Fritsch 
Journal of 
Tissue 
Engineering and 
Regenerative 
Medicine 2012 
 (Hart
mann-
Fritsch 
et al., 
2016) 
34 
Bilaminar Device of 
Poly(Lactic-co-
Glycolic 
Acid)/Collagen 
Cultured With 
Adipose-Derived 
Stem Cells for 
Dermal Regeneration 
Juliana 
Domingues 
Artificial 
Organs 2016 
 (Domi
ngues 
et al., 
2016) 
35 
Electrospun 
Composite Mats of 
Poly[(D,L-lactide)-
co-glycolide] and 
Collagen with High 
Porosity as Potential 
Scaffolds for Skin 
Tissue Engineering Ye Yang 
Macromolecula
r Materials and 
Engineering 2009 
 (Y. 
Yang 
et al., 
2009) 
36 
PLGA/gelatin hybrid 
nanofibrous scaffolds 
encapsulating EGF 
for skin regeneration 
Mohammad 
Norouzi 
Journal of 
Biomedical 
Materials 
Research Part A 2014 
 (Noro
uzi, 
Shaba
ni, 
Ahvaz, 
& 
Soleim
ani, 
2015) 
37 
Polycaprolactone-
based fused 
deposition modeled 
mesh for delivery of 
antibacterial agents to Erin Yiling Teo Biomaterials 2011 
 (Teo 
et al., 
2011) 
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infected wounds 
38 
Novel biodegradable 
sandwich-structured 
nanofibrous drug-
eluting membranes 
for repair of infected 
wounds: an in vitro 
and in vivo study 
Dave Wei-Chih 
Chen 
International 
Journal of 
Nanomedicine 2012 
 (D. 
W.-C. 
Chen 
et al., 
2012) 
39 
Fabrication and 
characterization of 
poly(l-lactide-co-
glycolide) knitted 
mesh-reinforced 
collagen–chitosan 
hybrid scaffolds for 
dermal tissue 
engineering Xingang Wang 
Journal of 
Mechanical 
Behaviour of 
Biomedical 
Materials 2012 
 (Xing
ang 
Wang 
et al., 
2012) 
40 
In vivo conjunctival 
reconstruction using 
modified PLGA 
grafts for decreased 
scar formation and 
contraction Sang Young Lee Biomaterials 2003 
 (S. Y. 
Lee et 
al., 
2003) 
41 
Bioburden-responsive 
antimicrobial PLGA 
ultrafine fibers for 
wound healing Somiraa Said 
European 
Journal of 
Pharmaceutics 
and 
Biopharmaceuti
cs 2012 
 (Said 
et al., 
2012) 
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42 
In Vitro and In 
Vivo Behaviors of the 
Three-layered 
Nanocarbonated 
Hydroxyapatite/Colla
gen/PLGA 
Composite Susan Liao 
Journal of 
Bioactive and 
Compatible 
Polymers 2010 
  (You 
et al., 
2013) 
43 
Three types of dermal 
grafts in rats: the 
importance of 
mechanical property 
and structural design Chuangang You 
Biomedical 
Engineering 
Online 2013 
 (You 
et al., 
2013) 
44 
Multilayer scaffold of 
electrospun PLA–
PCL–collagen 
nanofibers as a dural 
substitute Yu-fei Wang 
Journal of 
Biomedical 
Materials 
Research Part B 
Applied 
Biomaterials 2013 
 (Yu-
fei 
Wang, 
Guo, 
& 
Ying, 
2013) 
45 
Fabrication of Novel 
Scaffolds Containing 
Collagen-I/Polylactic 
Acid/Nanohydroxyap
atite via Co-
electrospinning 
Methods Zang Jun-ting 
Chemical 
Research In 
Chinese 
University 2010 
 (“Fabr
ication 
of 
Novel 
Scaffol
ds 
Contai
ning 
Collag
en-
I/Polyl
actic 
Acid/
Nanoh
ydroxy
apatite 
<em>v
ia</em
> Co-
electro
spinni
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ng 
Metho
ds,” 
n.d.) 
46 
Electrospinning of 
gelatin fibers and 
gelatin/PCL 
composite fibrous 
scaffolds. Zhang  Y. 
Journal of 
Biomedical 
Material 
Research B 
Applied 
Biomaterials 2005 
 (Y. 
Zhang, 
Ouyan
g, Lim, 
Ramak
rishna, 
& 
Huang, 
2005) 
47 
Co-electrospun 
poly(lactide-co-
glycolide), gelatin, 
and elastin blends for 
tissue engineering 
scaffolds Mengyan Li 
Journal of 
Biomedical 
Materials 
Research 2006 
 (M. Li 
et al., 
2006) 
48 
Synthesis and 
characterization of 
PLGA/collagen 
composite scaffolds 
as skin substitute 
produced by 
electrospinning 
through two different 
approaches 
Ali Rexa 
Sadeghi-
avalshahr 
Journal of 
Materials 
Science: 
Materials in 
Medicine  2017 
 (Sade
ghi-
avalsh
ahr, 
Khorsa
nd-
Ghaye
ni, 
Nokha
steh, 
Molavi
, & 
Naderi
-
Meshk
in, 
2017) 
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49 
Surface modification 
of nanofibrous 
polycaprolactone/gela
tin composite scaffold 
by collagen type I 
grafting for skin 
tissue engineering Sneh Gautam 
Materials 
Science and 
Engineering:C 2014 
 (Gaut
am, 
Chou, 
Dinda, 
Potdar, 
& 
Mishra
, 2014) 
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Table 8 
Papers with Collagen Scaffolds Used to Test Precision. 
  Paper Name First Author Journal Year Reference 
1 
The Use of a Pure 
Native Collagen 
Dressing for Wound 
Bed Preparation Prior 
to Use of a Living Bi-
layered Skin Substitute Naz Wahab 
Journal of 
the 
American 
College of 
Clinical 
Wound 
Specialists 2014 
(Wahab, 
Roman, 
Chakravart
hy, & 
Luttrell, 
2015) 
2 
The usefulness of the 
collagen and elastin 
sponge derived from 
salmon as an artificial 
dermis and scaffold for 
tissue engineering. 
Matsumoto 
Y 
Biomedical 
Research 
Internationa
l 2011 
 (Matsumot
o et al., 
2011) 
3 
Cultured Human 
Keratinocytes on Type 
I collagen Menbranes 
to Reconstitute the 
Epidermis 
Raymund 
Horch 
Tissue 
Engineering 2000 
 (Horch, 
Debus, 
Wagner, & 
Stark, 
2000) 
4 
Acellular Human 
Dermis Promotes 
Cultured Keratinocyte 
Engraftment 
Hans 
Rennekampff 
Journal of 
Burn Care 
& 
Rehabilitati
on 1997 
 (Renneka
mpff, 
Kiessig, 
Griffey, 
Greenleaf, 
& 
Hansbroug
h, 1997) 
5 
Closure of Abdominal 
Wall Defects Using 
Acellular Dermal 
Matrix Gary An 
The Journal 
of Trauma 
Injury, 
Infection, 
and Critical 
Care 2004 
 (An, 
Walter, & 
Nagy, 
2004) 
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6 
Role of wound healing 
myofibroblasts on re-
epithelialization of 
human skin. 
Veronique 
Moulin Burns 2000 
 (Moulin, 
Auger, 
Garrel, & 
Germain, 
2000) 
7 
Keratinocytes and 
Fibroblasts in a 
Human Skin 
Equivalent Model 
Enhance Melanocyte 
Survival and Melanin 
Synthesis After 
Ultraviolet Irradiation 
Michael 
Archambault 
Journal of 
Investigativ
e 
Dermatolog
y 1995 
 (Archamba
ult, Yaar, & 
Gilchrest, 
1995) 
8 
Skin Wound Closure 
in athymic mice with 
cultured human cells, 
biopolymers, and 
growth factors 
Steven 
Boyce 
Biomaterial
s 1991 
 (S. T. 
Boyce et 
al., 1991) 
9 
Surface Electrical 
Capacitance as a 
noninvasive Index of 
Epidermal Barrier in 
Cultured Skin 
Substitutes in Athymic 
Mice 
Steven 
Boyce 
The Society 
for 
Investigativ
e 
Dermatolog
y 1996 
 (S. T. 
Boyce et 
al., 1996) 
10 
Microstructure, 
rheological and wound 
healing properties of 
collagen-based gel 
from cuttlefish skin Mourad Jridi 
Internationa
l Journal of 
Biological 
Macromolec
ules 2015  (Jridi et 
al., 2015) 
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Table 9 
Papers with Polyester Scaffolds Used to Test Precision. 
  Paper Name First Author Journal Year Reference 
1 
Aloe vera incorporated 
biomimetic 
nanofibrous scaffold: a 
regenerative approach 
for skin tissue 
engineering 
S. Sugany
a Iranian 
Polymer 
Journal 2014  (Suganya et 
al., 2014) 
2 
In vivo optimization of 
a living dermal 
substitute employing 
cultured human 
fibroblasts on a 
biodegradable 
polyglycolic acid or 
polyglactin mesh 
Matthew 
Cooper 
Biomaterial
s 1991  (Cooper et 
al., 1991) 
3 
Combined effects of 
PLGA and vascular 
endothelial growth 
factor promote the 
healing of non-diabetic 
and diabetic wounds 
Kiran Kumar 
Chereddy 
Nanomedici
ne: 
Nanotechno
logy 
Biology and 
Medicine 2015  (Chereddy et 
al., 2015) 
4 
Combined effects of 
PLGA and curcumin 
on wound healing 
activigty 
Kiran Kumar 
Chereddy 
Journal of 
Controlled 
release 2013  (Chereddy et 
al., 2013) 
5 
Fabrication and 
structure analysis of 
poly(lactide-co-
glycolic acid)/silk 
fibroin hybrid scaffold 
for wound dressing 
Sheida 
Shahverdi 
Internationa
l Journal of 
Biological 
Macromolec
ules 2014  (Shahverdi 
et al., 2014)  
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applications 
6 
Enhancement of 
Diabetic Wound 
Repair Using 
Biodegradable 
Nanofibrous 
Metformin-Eluting 
Membranes: in Vitro 
and in Vivo 
Cheng-
Huang Lee 
ACS 
Applied 
Materials & 
Interfaces 2014  (C.-H. Lee 
et al., 2014) 
7 
Heparin-Conjugated 
Poly(lactic-co-glycolic 
acid) nanospheres 
enhance large-wound 
healing by delivering 
growth factors in 
platelet-rich plasma 
Wan-Geun 
La 
Artificial 
Organs 2014 (La & Yang, 
2015) 
8 
Fish collagen-based 
scaffold containing 
PLGA microspheres 
for controlled growth 
factor delivery in skin 
tissue engineering Huan Cao 
Colloids and 
Surfaces B: 
Biointerface
s 2015   (Cao et al., 
2015) 
9 
Controlled release of 
bioactive TGF-B from 
microspheres 
embedded within 
biodegradable 
hydrogels Alicia DeFail 
Biomaterial
s 2006 
 (DeFail, 
Chu, Izzo, & 
Marra, 2006) 
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10 
The influence of 
pancrease-derived 
stem cells on scaffold 
based skin 
regeneration. H. Salem 
Biomaterial
s 2009  (Salem et 
al., 2009) 
 
 
Table 10 
Papers with Hybrid Scaffolds Used to Test Precision. 
  Paper Name First Author Journal Year Reference 
1 
Efficient cutaneous 
wound healing using 
bixin-loaded PCL 
nanofibers in daibetic 
mice 
Pinzon-
Garcia AD 
Journal of 
Biomedical 
Materials 
Research 
Part B: 
Applied 
Biomaterial
s 2016 
 (Pinzón-
García et al., 
2016) 
2 
Fish collagen-based 
scaffold containing 
PLGA microspheres 
for controlled growth 
factor delivery in skin 
tissue engineering Huan Cao 
Colloids and 
Surfaces B: 
Biointerface
s 2015  (Cao et al., 
2015) 
3 
Experimental study on 
gelatin/polycaprolacta
m composite 
nanofiber scaffold in 
wound healing Long JH Journal  2006 
 (Long, Tan, 
Jiang, & 
Zhang, 2008)  
4 
Biocompatibility 
Evaluation of 
Electrospun Collagen, 
Gelatin, 
Polycaprolactone and 
their Composite 
Anuradha  
Elamparithi 
Indian 
Veterinary 
Journal 2016 
(Elamparithi, 
Ravi, 
Balachandra
n, Rao, & 
Paul, 2016) 
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Matrices in Rattus 
Norvegicus 
5 
Three Dimensional 
Tissue Engineering 
Scaffolds And Growth 
Factor Delivery 
System Comprised Of 
Electrospun Hybrid 
Mesh Of Poly 
(Caprolactone)/Collag
en Fibers And 
Hyaluronic Acid 
Hydrogel. AK Ekaputra 
Tissue 
Engineering 
and 
Regenerativ
e Medicine 
Internationa
l Society 
Asia Pacific 
Meeting 
2011 2011 
 (A. K. 
Ekaputra, 
Prestwich, 
Cool, & 
Hutmacher, 
n.d.)  
6 
Engineered Human 
Skin Fabricated using 
Electrospun Collagen-
PCL Blends 
Heather 
Powell 
Wound 
Repair and 
Regeneratio
n 2015 (Powell & 
Boyce, 2009) 
7 
In vitro and in vivo 
evaluation of novel 
implantable collagen–
chitosan–soybean 
phosphatidylcholine 
composite film for the 
sustained delivery of 
mitomycin C 
Zhenqing 
Hou 
Drug 
Developme
nt Research 2009 
 (Hou et al., 
2009) 
 
8 
Vascularization of 
LBL structured 
nanofibrous matrices 
with endothelial cells 
for tissue regeneration Lei Cui 
RSC 
Advances 2017  (Cui et al., 
2017)  
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9 
A novel hydrogel-
collagen composite 
improves functionality 
of an injectable 
extracellular matrix R. Hartwell 
Acta 
Biomateriali
a 2011 (Hartwell et 
al., 2011) 
10 
Enhancement of 
Diabetic Wound 
Repair Using 
Biodegradable 
Nanofibrous 
Metformin-Eluting 
Membranes: in Vitro 
and in Vivo 
Cheng-Huang 
Lee 
ACS 
Applied 
Materials & 
Interfaces 2014 (C.-H. Lee et 
al., 2014) 
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Statistical Analysis 
 
 
Table 11 
ANOVA results of healing rates across scaffold classes. 
 
  DF 
Sum of 
Squares 
Mean 
Square F Ratio Prob > F 
Scaffold Type 2 1.70943 0.85472 18.1677 <.0001 
Error 778 36.6017 0.04705     
C. Total 780 38.3112       
Level Number Mean Std Error 
Lower 
95% 
Upper 
95% 
Hybrid 164 0.17142 0.01694 0.13817 0.20466 
Natural 334 0.17111 0.01187 0.14781 0.19441 
Synthetic 283 0.26854 0.01289 0.24323 0.29385 
Rsquare 0.04462 
    Adj Rsquare 0.04216 
    Root Mean 
Square Error 0.2169 
    Mean of 
Response 0.20648 
    Observations 
(or Sum Wgts) 781 
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Table 12 
ANOVA Results of Healing Rates Across Fabrication Methods 
 
Source DF 
Sum of 
Squares 
Mean 
Square F Ratio Prob > F 
ECM Source 7 2.51661 0.35952 7.7639 <.0001 
Error 773 35.7946 0.04631     
C. Total 780 38.3112       
Rsquare 0.06569 
    Adj Rsquare 0.05723 
    Root Mean 
Square Error 0.21519 
    Mean of 
Response 0.20648 
    Observations 
(or Sum Wgts) 781 
    
Level Number Mean 
Std 
Error 
Lower 
95% Upper 95% 
Cell Line 3 0.52083 0.12424 0.2769 0.7647 
decellularized 19 0.12144 0.04937 0.0245 0.2183 
Decellularized 286 0.17922 0.01272 0.1542 0.2042 
Electrospinning 402 0.2316 0.01073 0.2105 0.2527 
Fused 
deposition 
Modeling 12 0.22902 0.06212 0.1071 0.351 
Pressed 2 0.99844 0.15216 0.6997 1.2971 
Purchased 48 0.16697 0.03106 0.106 0.2279 
Sigma Aldrich 9 0.02976 0.07173 -0.111 0.1706 
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